BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35454044)

  • 21. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
    Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
    Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.
    Gosline SJC; Tognon C; Nestor M; Joshi S; Modak R; Damnernsawad A; Posso C; Moon J; Hansen JR; Hutchinson-Bunch C; Pino JC; Gritsenko MA; Weitz KK; Traer E; Tyner J; Druker B; Agarwal A; Piehowski P; McDermott JE; Rodland K
    Clin Proteomics; 2022 Jul; 19(1):30. PubMed ID: 35896960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.
    Hackl H; Astanina K; Wieser R
    J Hematol Oncol; 2017 Feb; 10(1):51. PubMed ID: 28219393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
    Ding L; Ley TJ; Larson DE; Miller CA; Koboldt DC; Welch JS; Ritchey JK; Young MA; Lamprecht T; McLellan MD; McMichael JF; Wallis JW; Lu C; Shen D; Harris CC; Dooling DJ; Fulton RS; Fulton LL; Chen K; Schmidt H; Kalicki-Veizer J; Magrini VJ; Cook L; McGrath SD; Vickery TL; Wendl MC; Heath S; Watson MA; Link DC; Tomasson MH; Shannon WD; Payton JE; Kulkarni S; Westervelt P; Walter MJ; Graubert TA; Mardis ER; Wilson RK; DiPersio JF
    Nature; 2012 Jan; 481(7382):506-10. PubMed ID: 22237025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
    Çelik H; Lindblad KE; Popescu B; Gui G; Goswami M; Valdez J; DeStefano C; Lai C; Thompson J; Ghannam JY; Fantoni G; Biancotto A; Candia J; Cheung F; Sukumar G; Dalgard CL; Smith RH; Larochelle A; Dillon LW; Hourigan CS
    Blood Adv; 2020 Jan; 4(2):367-379. PubMed ID: 31985806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming.
    Patel SA
    Cancer Lett; 2022 May; 533():215579. PubMed ID: 35124146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
    Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
    Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukemia stem cell and clonal evolution].
    Yoshimi A; Kurokawa M
    Nihon Rinsho; 2014 Jun; 72(6):1012-7. PubMed ID: 25016797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
    Braun S; Gerhartz HH; Schmetzer HM
    Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2
    Song J; Du L; Liu P; Wang F; Zhang B; Xie Y; Lu J; Jin Y; Zhou Y; Lv G; Zhang J; Chen S; Chen Z; Sun X; Zhang Y; Huang Q
    Cancer Commun (Lond); 2021 Sep; 41(9):867-888. PubMed ID: 34196511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
    Li S; Mason CE; Melnick A
    Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of recurrent gene mutations in acute myeloid leukemia.
    Yu J; Li Y; Zhang D; Wan D; Jiang Z
    Exp Hematol Oncol; 2020; 9():4. PubMed ID: 32231866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can We Use an Algorithm as an "Ariadne's Thread" to Escape the Maze of Mitral Regurgitation Phenotype?
    Beneki E; Dimitriadis K; Tsioufis K; Aggeli K
    J Am Soc Echocardiogr; 2024 Mar; 37(3):373. PubMed ID: 37839618
    [No Abstract]   [Full Text] [Related]  

  • 39. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
    Krönke J; Bullinger L; Teleanu V; Tschürtz F; Gaidzik VI; Kühn MW; Rücker FG; Holzmann K; Paschka P; Kapp-Schwörer S; Späth D; Kindler T; Schittenhelm M; Krauter J; Ganser A; Göhring G; Schlegelberger B; Schlenk RF; Döhner H; Döhner K
    Blood; 2013 Jul; 122(1):100-8. PubMed ID: 23704090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Boissel N; Petit A; Bucci M; Geffroy S; Lapillonne H; Renneville A; Ragu C; Figeac M; Celli-Lebras K; Lacombe C; Micol JB; Abdel-Wahab O; Cornillet P; Ifrah N; Dombret H; Leverger G; Jourdan E; Preudhomme C
    Blood; 2016 May; 127(20):2451-9. PubMed ID: 26980726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.